Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist
出版年份 2021 全文链接
标题
Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 15, Pages 10581-10605
出版商
American Chemical Society (ACS)
发表日期
2021-07-27
DOI
10.1021/acs.jmedchem.1c00683
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- AMYLOID-β AND TAU AGGREGATION DUAL-INHIBITORS: A SYNTHETIC AND STRUCTURE-ACTIVITY RELATIONSHIP FOCUSED REVIEW
- (2021) Daniela Malafaia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent advances of dual FGFR inhibitors as a novel therapy for cancer
- (2021) Qi Liang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel and Potent PARP/PI3K Dual Inhibitors for the Treatment of Cancer
- (2021) Zhengyang Wu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ Modulator
- (2021) Markus Hartmann et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bicyclic Diazepinones as Dual Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels and the Norepinephrine Transporter
- (2021) José Luis Díaz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer
- (2021) Yuhao Ren et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Dual-Target μ-Opioid Receptor and Dopamine D3 Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management
- (2021) Alessandro Bonifazi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR)
- (2021) João P.S. Ferreira et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Lanosterol 14α-demethylase (CYP51)/histone deacetylase (HDAC) dual inhibitors for treatment of Candida tropicalis and Cryptococcus neoformans infections
- (2021) Tianbao Zhu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles
- (2021) Muhamad Mustafa et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Dual Targeting of Norepinephrine Transporter (NET) Function and Thyrointegrin αvβ3 Receptors in the Treatment of Neuroblastoma
- (2020) Ozlem Ozen Karakus et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Structural Optimization of Dual FXR/PPARδ Activators
- (2020) Simone Schierle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes
- (2020) Jingjing Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ1 Receptor Antagonist Clinical Candidate for the Treatment of Pain
- (2020) Mónica García et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Structure–Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
- (2020) Kerstin Hiesinger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer
- (2020) Guoguo Jin et al. ONCOGENE
- Discovery of novel PARP/PI3K dual inhibitors with high efficiency against BRCA-proficient triple negative breast cancer
- (2020) Junwei Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel naphthylamide derivatives as dual-target antifungal inhibitors: Design, synthesis and biological evaluation
- (2020) Yunfei An et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Novel Dual Histone Deacetylases (HDACs) and Mammalian Target of Rapamycin (mTOR) Target Inhibitor as a Promising Strategy for Cancer Therapy
- (2019) Yong Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- A new, vasoactive hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety
- (2019) Kitti Szőke et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
- (2019) Junting Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Dual Poly(ADP-ribose)polymerase and Phosphoinositide 3-Kinase Inhibitors as a Promising Strategy for Cancer Therapy
- (2019) Junwei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma
- (2018) Dizhong Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer’s Disease Drug Discovery
- (2018) Xue-Yang Jiang et al. ACS Medicinal Chemistry Letters
- Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
- (2018) Ewgenij Proschak et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of potent and selective PPARα/δ dual antagonists and initial biological studies
- (2018) Jason D. Jacintho et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Designing multi-targeted agents: An emerging anticancer drug discovery paradigm
- (2017) Rong-geng Fu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The potential of combi-molecules with DNA-damaging function as anticancer agents
- (2017) Guohui Sun et al. Future Medicinal Chemistry
- Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors
- (2017) Guoqiang Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis
- (2017) Jurema Schmidt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat
- (2017) Lianbin Yao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
- (2017) Patrizia Mondello et al. Oncotarget
- Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPARγ
- (2017) Jun Zhang et al. Oncotarget
- Propargylamine Containing Compounds as Modulators of Proteolytic Cleavage of Amyloid Protein Precursor: Involvement of MAPK and PKC Activation
- (2017) Orit Bar-Am et al. JOURNAL OF ALZHEIMERS DISEASE
- Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC
- (2016) Fan-Wei Peng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design of Potent Nicotinamide Phosphoribosyltransferase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities
- (2016) Jinhong Bai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Janus Kinase 2 (JAK2) and Histone Deacetlyase (HDAC) Bispecific Inhibitors Based on Pacritinib and Evidence of Dual Pathway Inhibition in Hematological Cell Lines
- (2016) Eugene Guorong Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer’s Disease
- (2016) Obdulia Rabal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer’s Disease
- (2015) Rong Sheng et al. ACS Chemical Neuroscience
- Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core
- (2015) Prasanna Sivaprakasam et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Macrocyclic compounds as anti-cancer agents: Design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2
- (2015) Cheng-Qing Ning et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Temozolomide-based combination for advanced neuroendocrine neoplasms: a systematic review of the literature
- (2015) Omar Abdel-Rahman et al. Future Oncology
- Novel Bioactive Hybrid Compound Dual Targeting Estrogen Receptor and Histone Deacetylase for the Treatment of Breast Cancer
- (2015) Chu Tang et al. JOURNAL OF MEDICINAL CHEMISTRY
- PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain
- (2015) Jennine M. Dawicki-McKenna et al. MOLECULAR CELL
- Review of the Structural and Dynamic Mechanisms of PPARγPartial Agonism
- (2015) Alice J. Kroker et al. PPAR Research
- Design, Synthesis, and Biological Evaluation of Indole Biphenylcarboxylic Acids as PPARγ Antagonists
- (2015) Alice Asteian et al. ACS Medicinal Chemistry Letters
- Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors
- (2015) Shipeng He et al. ACS Medicinal Chemistry Letters
- Extending the Structure–Activity Relationship of Anthranilic Acid Derivatives As Farnesoid X Receptor Modulators: Development of a Highly Potent Partial Farnesoid X Receptor Agonist
- (2014) Daniel Merk et al. JOURNAL OF MEDICINAL CHEMISTRY
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- Acid-cleavable thiomaleamic acid linker for homogeneous antibody–drug conjugation
- (2013) Lourdes Castañeda et al. CHEMICAL COMMUNICATIONS
- A novel series of tacrine–selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer's disease
- (2013) Chuanjun Lu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- New developments around histamine H3receptor antagonists/inverse agonists: a patent review (2010 – present)
- (2013) Dorota Łażewska et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- ZRX1, the first EGFR inhibitor-capecitabine based combi-molecule, requires carboxylesterase-mediated hydrolysis for optimal activity
- (2013) Maria Ait-Tihyaty et al. INVESTIGATIONAL NEW DRUGS
- Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability
- (2013) Benjamin E. L. Lauffer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design and Synthesis of Dual-Action Inhibitors Targeting Histone Deacetylases and 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase for Cancer Treatment
- (2013) Jhih-Bin Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of a Chimeric c-Src Kinase and HDAC Inhibitor
- (2013) Kristin S. Ko et al. ACS Medicinal Chemistry Letters
- Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain
- (2012) Jin H. Park et al. BIOCHEMICAL JOURNAL
- Design, synthesis, and evaluation of imidazo[4,5-c]pyridin-4-one derivatives with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ
- (2012) Agustin Casimiro-Garcia et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Characterization of Telmisartan-Derived PPARγ Agonists: Importance of Moiety Shift from Position 6 to 5 on Potency, Efficacy and Cofactor Recruitment
- (2012) Lena Herbst et al. ChemMedChem
- Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
- (2012) C. Qian et al. CLINICAL CANCER RESEARCH
- Structural basis for telmisartan-mediated partial activation of PPAR gamma
- (2012) Yasushi Amano et al. HYPERTENSION RESEARCH
- Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction
- (2012) Andrew R. Kompa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Prodrugs of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), More Than Meets the Eye: A Critical Review
- (2012) Amjad Qandil INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure–Activity Relationship Analysis and Biological Evaluations
- (2012) Guoqiang Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- New Tacrine–4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties
- (2012) María Isabel Fernández-Bachiller et al. JOURNAL OF MEDICINAL CHEMISTRY
- VS-5584, a Novel and Highly Selective PI3K/mTOR Kinase Inhibitor for the Treatment of Cancer
- (2012) S. Hart et al. MOLECULAR CANCER THERAPEUTICS
- Automated design of ligands to polypharmacological profiles
- (2012) Jérémy Besnard et al. NATURE
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multi-Target Drugs: The Trend of Drug Research and Development
- (2012) Jin-Jian Lu et al. PLoS One
- 6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase
- (2011) Jing Tang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Multi-Target-Directed Ligands in Alzheimer's Disease Treatment
- (2011) M. Bajda et al. CURRENT MEDICINAL CHEMISTRY
- Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer
- (2011) Daniel P. Sutherlin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Series of Imidazo[4,5-b]pyridines with Dual Activity at Angiotensin II Type 1 Receptor and Peroxisome Proliferator-Activated Receptor-γ
- (2011) Agustin Casimiro-Garcia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus Kinase 2/Fms-Like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and Lymphoma
- (2011) Anthony D. William et al. JOURNAL OF MEDICINAL CHEMISTRY
- 3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase
- (2011) Jing Tang et al. JOURNAL OF MEDICINAL CHEMISTRY
- GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway
- (2011) J. J. Wallin et al. MOLECULAR CANCER THERAPEUTICS
- Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor
- (2011) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells
- (2011) Michele Cea et al. PLoS One
- Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer
- (2011) Matthew T. Burger et al. ACS Medicinal Chemistry Letters
- Pharmacophore and structure–activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase
- (2010) Zhengqiang Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dual-target-directed 1,3-diphenylurea derivatives: BACE 1 inhibitor and metal chelator against Alzheimer’s disease
- (2010) Wenhai Huang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Characterization of new PPARγ agonists: Benzimidazole derivatives—importance of positions 5 and 6, and computational studies on the binding mode
- (2010) Matthias Goebel et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and biological activities of novel indole derivatives as potent and selective PPARγ modulators
- (2010) Yann Lamotte et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Tacrine Derivatives and Alzheimers Disease
- (2010) V. Tumiatti et al. CURRENT MEDICINAL CHEMISTRY
- Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer
- (2010) Xiong Cai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity
- (2010) Siavosh Mahboobi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Assembly/Disassembly of Drug Conjugates Using Imide Ligation
- (2010) Reda Mhidia et al. ORGANIC LETTERS
- N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and Integrase
- (2010) Jing Tang et al. ACS Medicinal Chemistry Letters
- Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: Synthesis, biological evaluation and nitric oxide release studies
- (2009) Khaled R.A. Abdellatif et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- NO-NSAIDs: Gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs
- (2009) Kumar V.S. Nemmani et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Rational Design of Multitargeted Tyrosine Kinase Inhibitors: A Novel Approach
- (2009) Sylvie Barchéchath et al. Chemical Biology & Drug Design
- Characterization of New PPARγ Agonists: Benzimidazole Derivatives - the Importance of Position 2
- (2009) Matthias Goebel et al. ChemMedChem
- Characterization of New PPARγ Agonists: Analysis of Telmisartan’s Structural Components
- (2009) Matthias Goebel et al. ChemMedChem
- Design of Chimeric Histone Deacetylase- and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF-Rβ, and Histone Deacetylases†
- (2009) Siavosh Mahboobi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Optimization of Arylamides as Inhibitors of Soluble Epoxide Hydrolase
- (2009) Anne B. Eldrup et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antidepressant specificity of serotonin transporter suggested by three LeuT–SSRI structures
- (2009) Zheng Zhou et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Flavonols and flavones as BACE-1 inhibitors: Structure–activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features
- (2008) Yoshiari Shimmyo et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: Introducing a diketoacid functionality into delavirdine
- (2008) Zhengqiang Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064
- (2008) Adwoa Akwabi-Ameyaw et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Statins Increase p21 through Inhibition of Histone Deacetylase Activity and Release of Promoter-Associated HDAC1/2
- (2008) Y.-C. Lin et al. CANCER RESEARCH
- From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage
- (2008) S. Giordano et al. CURRENT MEDICINAL CHEMISTRY
- Synthesis, Structure−Activity Relationships, and Biological Profiles of a Quinazolinone Class of Histamine H3Receptor Inverse Agonists
- (2008) Tsuyoshi Nagase et al. JOURNAL OF MEDICINAL CHEMISTRY
- 4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1
- (2008) Keith A. Menear et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
- (2008) Andrea Cavalli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combi-targeting concept: an optimized single-molecule dual-targeting model for the treatment of chronic myelogenous leukemia
- (2008) A. Katsoulas et al. MOLECULAR CANCER THERAPEUTICS
- Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist
- (2008) L. E. Tavera-Mendoza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now